Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 186

Emailed: 0

PDF Downloaded: 1915


Sahoo, Dehury, Mohapatra, Mohapatra, and Mohanty: Cutaneous adverse drug reactions in geriatric patients in Odisha


Introduction

The medical prescription for patients over 60 years accounts for one-half of total prescriptions.1

Adverse drug reaction (ADR) is defined as a response to a drug which is noxious & unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modifications of physiological function.2

There was increased risk of adverse Drug Reactions (ADRs) in elderly because physiological & pathological changes in Geriatric population can alter pharmacokinetics & pharmacodynamics of administered drugs.2

ADRs rank as one of the top leading causes of death & illness in the developed world.3 Recent data of USFDA shows that ADRs now ranks the 4th to 6th most common cause of death.3 Detection and prevention of ADRs at the earliest is very important to reduce the morbidity & mortality keeping in view the high healthcare cost involved in the management of ADRs.

Studies from out of the country as well as India have expressed that polypharmacy is common and correlated with raised potential for adverse drug reactions, inappropriate prescription and drug Interactions.4, 5, 6, 7, 8

The ADRs in elderly adults are four times more common than younger adults. One in six hospital admissions of elderly patients is due to ADRs.9, 10, 11

Literature Survey reveals that out of all Geriatric Adverse Drug Reactions in India, 5-7 % were cutaneous ADRs.12, 13, 14, 15

Very few studies conducted regarding this in India & no such study in Odisha.

Hence this cutaneous ADRs study in Geriatric patients is taken up in our tertiary care hospital.

Aims & Objectives

This study was aimed to study cutaneous Adverse Drug Reactions with following objectives

  1. Prevalence of cutaneous adverse drug reactions.

  2. Profile of cutaneous adverse drug reactions.

  3. Causality assessment by WHO-UMC Scale & Naranjo adverse drug reaction probability scale.

  4. Severity assessment by HARTWIG’S scale.

  5. Preventability by schumock & Thorton scale in our tertiary care teaching hospital.

Materials and Methods

Study design

  1. Study type - A Hospital based observational study.

  2. Study site – Dept of Pharmacology (ADR monitoring centre) in collaboration with Medicine Department and Skin &VD department of SCB medical college & Hospital, Cuttack.

  3. Study period - August 2017 – July 2018.

  4. Informed consent was taken from all patients.

Inclusion criteria

  1. Geriatric Patients (≥ 60 yrs) of both sexes presenting in Medicine Department and Skin &VD department with all types of suspected ADRs were included in the study.

  2. Details of the cutaneous ADRs were evaluated.

Exclusion criteria

  1. Patients with drug abuse.

  2. Patients with intentional or accidental poisoning.

  3. The detailed information of Patients presented with ADRs were filled up in Suspected ADR Reporting form of Indian pharmacopoeia commission.

  4. Prevalence of cutaneous Adverse Drug Reactions among all ADRs in Geriatric Patients.

  5. Profile of cutaneous ADRs were evaluated.

  6. The causality assessment done by WHO-UMC Scale & Naranjo ADR probability scale.

  7. Severity assessed by Hartwig’s Scale.

  8. Preventability of ADRs assessed by Schumock & Thornton scale.

Results

Table 1

Number & % of ADRs in different body system

System involved

No. of ADR N-102

% of ADR

Cutaneous

48

47

Metabolic

33

32.3

GI

12

11.7

CNS

5

4.9

Respiratory

4

3.9

Total ADRs in geriatric patients-102

The above table depicts the number of ADRs affecting different body systems. Most common body system involved was cutaneous i.e., 100 (42.3 %) ADRs, followed by Metabolic i.e., 68(28.8 %) ADRs. Followed by GI system i.e., 12(11.7%), CNS i.e.,5(4.9%), Respiratory i.e.,4(3.9%).Table 1

Table 2

Demographic profile of cutaneous ADRs in geriatric patients.

Gender

Number & % ADRs

Male

33(68%)

Female

15(32%)

Total ADRs in geriatric patients -102, out of which cutaneous ADRs -48

The above table depicts the demographic profile of cutaneous ADRs in geriatric patients. Maximum 68% cutaneous ADRs found in males.Table 2

Table 3

Number & % of cutaneous ADRs in different age group

Age Groups (Years)

Number & % of ADRs

Young Old(60-69 YR)

31(65%)

Old Old(70-79 YR)

17(35%)

Very Old(≥80 YR)

0

Total ADRs in geriatric patients -102, out of which cutaneous ADRs -48

The above table depicts Number and percentage of cutaneous ADRs in different age group. Maximum 65% of cutaneous ADRs found in young-old age group (60-69yr).Table 3

Table 4

Type & % of cutaneous ADRS due to different drugs

Type of dermatological ADRs

Number of ADRs with %

Drugs causing ADRs

RASH

13(27%)

Ceftriaxone, Phenytoin, Ofloxacin, Cipro OZ, Paracetamol, Azithromycin

SJS

9(18.7%)

Cefuroxime, Linezolid, Ofloxacin, Nimesulide

Pruritus

7(14.5%)

Infusion Ofloxacin

Erythema

6(12.5%)

Levocetrizine, Phenytoin

Hypersensitivity

5(10.4%)

Dapsone

FDE

4(8.3%)

Ofloxacin, Nimesulide

TEN

3(6.2%)

Amoxyclav, Cefosulba

SJS-TEN

1(2%)

Piperacillin-Tazobactam

The above table depicts type and percentage of cutaneous ADRs due to different drugs. Maximum cutaneous ADRs is rash (27%) found in our study due to ceftriaxone, phenytoin, ofloxacin, ciprofloxacin-ornidazole, paracetamol, azithromycin followed by sjs (18.7%) due to cefuroxime, linezolid, ofloxacin, nimesulide.Table 4

Table 5

% of different cutaneous ADRs

Rash

13(27%)

SJS

9(18.7%)

Pruritus

7(14.5%)

Erythema

6(12.5)%

Hypersensitivity

5(10.4%)

FDE

4(8.3%)

TEN

3(6.2%)

SJS-TEN

1(2%)

The above table depicts rash (27%) most common cutaneous ADRs found in our study.

Table 6

Causality category

WHO-UMC scale Number of ADRs (%)

Naranjo ADR probability scale Number of ADRs (%)

Certain/definite

0

39(81%)

Probable

35(73%)

9(19%)

Possible

13(27%)

0

Unlikely

0

0

Conditional/Unclassifiable

0

Total

48(100%)

48(100%)

The above table shows the percentage of ADRs attributed to different categories of both WHO-UMC and Naranjo scales. WHO-UMC scale shows that 13(27%) ADRs in possible category, 35(73%) in probable category. Naranjo scale shows that 9(19%) ADRs in possible category and 39(81%) ADRs in probable category.Table 6

Table 7

Severity

Level

Number of ADRs

Total (%)

Mild

1

0

20.8%

2

10

Moderate

3

0

62.5%

4

30

Severe

5

8

16.6%

6

0

7

0

The above table shows Hartwig’s severity scale, according to it 10 (20.8 %) ADRs were of mild intensity, 30(62.5%) ADRs were of moderate intensity & 8(16.6%) ADRs were of severe intensity.Table 7

Table 8

Preventability of ADRs.

Definitely Preventable

28 Cutaneous ADRs

Probably Preventable

20 Cutaneous ADRs

Not Preventable

0

Total cutaneous ADRs in geriatric patient-48

The above table shows preventability by schumock& Thornton scale, According to it 28 (58.3%) ADRs were definitely preventable, 20(41.7%) were probably preventable.Table 8

Discussion

  1. In our study 48(47%) ADRs collected over 1 year in contrast to 7 (7.21%) ADRs by Maheshkumar pauldurai et al (Jan 2013- Jan 2014) out of Geriatric ADRs in respective studies.

  2. In our study 35.4% ADRs in age group 70-79 years with no reports ≥ 80 years which may be due to less patients above 80yrs coming to Medicine and Skin &VD department.

  3. Maximum 68% cutaneous ADRs was observed in the males in our study which nearly corroborate to the study by Devi SLS et al.

  4. In our study cutaneous ADRs (47%) found to be most common out of total geriatric ADRs in contrast to commonest ADR in GI system (29.89%) by Maheshkumar pauldurai et al.

  5. In our study Drugs induced rash (27%) was the maximum type of cutaneous ADRs in comparison to 5% rash by Devi SLS et al. 9

Conclusion

  1. Most of the ADRs were probably caused due to the drug, were moderate in intensity and definitely preventable.

  2. Maximum Cutaneous ADRs found in males.

Acknowledgments

The authors would like to thank Dr Kaliprasad pattnaik, Mr. Sahoo for their kind support.

Conflict of interest

The authors have no conflicts of interest regarding this investigation.

Source of Funding

None.

References

1 

Geneva: World Health Organization. Looking at the Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines. Geneva: WHO; 2004.Available from website- http://www.whqlibdoc.who.int/hq/2004/WHO_EDM_2004.8.pdf. [Cited on 2009 Dec 15]

2 

M Pauldurai D Kannaaiyan R Rao Adverse drug reaction monitoring in geriatric patients of rural teaching hospitalDer Pharmacia Lettre201571218793

3 

J Lazarou BH Pomeranz PN Corey Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studiesJAMA1998279151200510.1001/jama.279.15.1200

4 

A Conforti D Costantini F Zanetti U Moretti M Grezzana R Leone Adverse drug reactions in older patients: an Italian observational prospective hospital studyDrug Healthc Patient Saf20124758010.2147/DHPS.S29287

5 

CK Mannesse FH Derkx MA De Ridder AJ Man TJ van der Cammen Contribution of adverse drug reactions to hospital admis­sion of older patientsAge Ageing200029135910.1093/ageing/29.1.35

6 

G Onder C Pedone F Landi Adverse drugreactionsascause of hospitaladmissions:results fromthe Italian Group ofPharma- co epidemiology in the Elderly (GIFA)J Am Geriatr Soc2002501219628

7 

M Franceschi C Scarcelli V Niro Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patientsDrug Saf200831654556

8 

P Olivier L Bertrand M Tubery D Lauque JL Montastruc M Lapeyre-Mestre Hospitalizations because of adverse drug reac­tions in elderly patients admitted through the emergency department: a prospective surveyDrugs Aging200926647582

9 

SLS Devi S Basalingappa SC Abilash A study of adverse drug reactions among elderly patients in a tertiary care hospitalInt J Basic Clin Pharmacol20176818949

10 

K Nagaraju S Manasa Manjunath R Pharmacovigilance Study In Geriatric PopulationAsian J Pharm Clin Res2015823959

11 

CR Jayanthi M Renuka P Panchaksharimath An observational Study to analyze the Adverse drug Reactions among the Elderly at A Tertiary Care HospitalBiomed Pharmacol J201710110.13005/bpj/1115

12 

T Hanlon KE Schmader MJ Koronkowski M Weinberger PB Landsman GP Samsa Adverse drug events in high risk older outpatientsJ Am Geriatr Soc1997458945810.1111/j.1532-5415.1997.tb02964.x

13 

D’ Mandavi S Cruz A Sachdev P Tiwari EditorialJ Pharm Health Ser Res201121293410.1111/j.1759-8893.2011.00048.x

14 

LR Tulner IM Kuper SV Frankfort JP Van Campen CH Koks DP Brandjes Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactionsAm J Geriatr Pharmacother2009729310410.1016/j.amjopharm.2009.04.006

15 

HJ Beijer CJ De Blaey Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studiesPharm World Sci2002242465410.1023/a:1015570104121



jats-html.xsl

© 2022 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)